Navigation Links
Chiltern Appoints Jane Turner as Late Phase Director for Europe
Date:2/27/2009

LONDON, Feb. 27 /PRNewswire/ -- Chiltern a leading global clinical research organization announced today that it has appointed Ms. Jane Turner to the post of Director, Late Phase, Europe.

Ms. Turner brings over 24 years of experience to her new position in Chiltern's global Late Phase Organization. Ms. Turner previously held executive positions in both CRO and Pharmaceutical companies, enabling her to acquire considerable knowledge of the operational side of management in both industries. In her most recent position, Jane worked on the management of Late Phase studies with focus on a European setting. Jane's operational base will be Chiltern's global headquarters in Slough, United Kingdom. Jane received a B.Pharm from the University of Nottingham and a Diploma in Clinical Science from the University of Wales.

"I am pleased that Jane chose to bring her expertise and experience to Chiltern," said Steve Albrecht, Chiltern's Senior Director, Late Phase (global). "Our global Late Phase Team has grown significantly over the past few years and Jane's extensive business and operational experience will help us bring innovative and high quality solutions to exceed our sponsors varied Late Phase needs," Steve added.

"I am delighted to join Steve and the global Late Phase group at Chiltern," Jane Turner stated. "There is an increasing demand from both the regulatory authorities and the public for Late Phase studies especially in the domain of drug safety. These requests can negatively affect our sponsors with added costs and time delays; therefore it is imperative that CROs continue to look for innovative solutions while preserving the integrity of the data and the safety of the subjects."

"Jane adds significant strength to our global Late Phase Team," commented James Esinhart, Executive Vice President, Biometrics & Late Phase. "We are experiencing increased demand for Chiltern's Late Phase services utilizing our expertise, our global Call Centers and our web-based data collection platforms to provide sponsors with the unique services required for their marketed products. We are looking forward to Jane's keen insights as we customize our services to meet the needs of the key stakeholders, ie, our sponsors, the regulatory authorities, and the patients."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern has 1,400 employees located in 24 offices throughout Europe, the Americas and Asia. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.

    For More Information Contact:
    Catherine Lemercier                       Richard Baptista
    Chiltern International, Inc.              Chiltern International Ltd.
    2111 Palomar Airport Road                 171 Bath Road
    Suite 200                                 Slough
    Carlsbad                                  Berkshire
    CA 92011                                  SL1 4AA
    USA                                       UNITED KINGDOM
    Tel: 1 (760) 707 5025                     Tel: +44 (0) 1753 512 000
    Fax: 1 (760) 707 5022                     Fax: +44 (0) 1753 511 116
    Email:                                    Email:
    Catherine.Lemercier@chiltern.com          Richard.Baptista@chiltern.com


'/>"/>
SOURCE Chiltern
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chilterns Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom
2. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership
3. Chiltern Enhances Its Portfolio of Electronic Data Capture (EDC) Services With the Addition of Hosting and eCRF Design Services for DataLabs (by ClinPhone) and Medidata Rave(R) Certification
4. Chiltern Expands Its Global Reach to Latin America
5. Chiltern Announces New Expansion in Portugal
6. Chiltern Opens a New Office in Russia
7. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
8. Chiltern Wins Top Prize
9. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
10. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
11. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
Breaking Medicine Technology: